BG Medicine

^{, Nasdaq: BGMD}

Markets a biomarker diagnostic test for heart failure and is developing others.

Industry: Health Care

First Day Return: +15.0%

BGMD

Markets a biomarker diagnostic test for heart failure and is developing others.

IPO News for BG Medicine

BG Medicine quiet period ends March 15 03/10/11
BG Medicine prices IPO at $7, half of its original $13-$15 price range 02/04/11
BG Medicine refiles for IPO, halves proposed offer price 02/01/11

IPO Data
IPO Date	02/03/2011
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$35
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.bg-medicine.com
Headquarters	Waltham, MA, United States
Founded	2000
Employees at IPO	51

IPO News for BG Medicine

BG Medicine quiet period ends March 15 03/10/11
BG Medicine prices IPO at $7, half of its original $13-$15 price range 02/04/11
BG Medicine refiles for IPO, halves proposed offer price 02/01/11

BG Medicine (BGMD) Performance